// App-Quantinova.ai

: Incidence and clinical characteristics of patients with LAPC and mesenteric vein thrombosis and current treatment paradigm.

Researchers

Presenter

  • Amer H. Zureikat

Principal Investigators

  • Charles D. Lopez

  • Kenneth Meredith

  • Emmanuel E. Zervos

  • Hassan Hatoum

  • Ki Y. Chung

  • Alex Tsobanoudis

  • Daniel James Berg

  • Antonio Ucar

  • Reza Nazemzadeh

  • Susan Elaine Bates

  • Karyn A. Goodman

  • Thor Johnson

  • Nainesh Parikh

  • Brian Kouri

  • Christopher Laing

  • Brian A. Boone

  • Imtiaz Qureshi

  • Ramtin Agah

Medical Centers

  • East Carolina Univ, Winterville, NC

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Sarasota Memorial Health Care System, Sarasota, FL

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • RenovoRx, Los Altos, CA

  • Medcl Univ of South Carolina, Charleston, SC

  • Mount Sinai Department of Radiation Oncology, New York, NY

  • Wake Forest Baptist Health, Winston-Salem, NC

  • Oregon Health and Science University, Portland, OR

  • University of Oklahoma School of Medicine, Oklahoma City, OK

  • University of Iowa Hospitals and Clinics, Iowa City, IA

  • Miami Cancer Institute, Miami, FL

  • Columbia University Medical Center, New York, NY

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • Sutter Cancer Center, Sacramento, CA

  • University of Pittsburgh Medical Center, Pittsburgh, PA

  • Department of Statistics, West Virginia University, Morgantown, WV

  • Prisma Health Cancer Institute, Boiling Springs, SC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Paclitaxel

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT03257033

Sponsors

  • N/A

Result

  • N/A